Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells (Q40094556)
Jump to navigation
Jump to search
scientific article published on 7 May 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells |
scientific article published on 7 May 2008 |
Statements
1 reference
Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells (English)
1 reference
1 reference
1 reference
Sophie Doublier
1 reference
Costanzo Costamagna
1 reference
Elisabetta Aldieri
1 reference
Gianpiero Pescarmona
1 reference
Amalia Bosia
1 reference
7 May 2008
1 reference
1 reference
74
1 reference
2
1 reference
476-484
1 reference
Identifiers
1 reference
1 reference